Assembly Biosciences to Present Topline Phase 1a Data on Hepatitis Delta Virus Entry Inhibitor ABI-6250 at the EASL Congress 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. CRWV

Go back to Assembly Biosciences to Present Topline Phase 1a Data on Hepatitis Delta Virus Entry Inhibitor ABI-6250 at the EASL Congress 2026
(NASDAQ: ASMB) Delayed: 22.96 +0.43 (1.91%)
Previous Close $22.53    52 Week High $14.50 
Open $22.60    52 Week Low $4.33 
Day High $23.69    P/E N/A 
Day Low $22.35    EPS $0.00 
Volume 144,396